Answers are grounded in this paper and cite their sources.
Systematic review assesses efficacy of alternative versus standard dosing strategies in multiple sclerosis, suggesting implications for treatment approaches.
To assess the efficacy of alternative dosing strategies (ADS), including extended-interval dosing (EID) and dose reduction, compared with standard dosing strategies (SDS) of anti-CD20 monoclonal antibodies in multiple sclerosis (MS).
No takes yet. Share an insight, caveat, or question.
Gudapati et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: